Suzy Scholl

9.6k total citations · 3 hit papers
78 papers, 6.4k citations indexed

About

Suzy Scholl is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Suzy Scholl has authored 78 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 23 papers in Cancer Research and 20 papers in Immunology. Recurrent topics in Suzy Scholl's work include Immunotherapy and Immune Responses (17 papers), Breast Cancer Treatment Studies (15 papers) and Cervical Cancer and HPV Research (11 papers). Suzy Scholl is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Breast Cancer Treatment Studies (15 papers) and Cervical Cancer and HPV Research (11 papers). Suzy Scholl collaborates with scholars based in France, United States and Netherlands. Suzy Scholl's co-authors include P Pouillart, Melody Cobleigh, Nicholas J. Robert, Virginia Paton, Dennis J. Slamon, Debu Tripathy, Charles L. Vogel, Louis Fehrenbacher, Steven Shak and Janet Wolter and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Suzy Scholl

75 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

1999 2.2k citations Suzy Scholl et al. profile →
Therapeutic vaccines for cancer: an overview of clinical trials

2014 614 citations Suzy Scholl et al. profile →
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

2006 548 citations Suzy Scholl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzy Scholl France	30	3.8k	1.8k	1.7k	1.6k	1.4k	78	6.4k
Hans‐Peter Sinn Germany	47	3.4k 0.9×	2.9k 1.6×	3.3k 1.9×	1.3k 0.8×	631 0.4×	260	8.3k
Marcella Mottolese Italy	45	3.1k 0.8×	3.5k 2.0×	1.5k 0.9×	669 0.4×	798 0.6×	224	7.2k
Pauline Wimberger Germany	43	3.4k 0.9×	2.3k 1.3×	1.4k 0.8×	747 0.5×	1.1k 0.8×	311	8.0k
E. Kubista Austria	43	3.7k 1.0×	2.0k 1.1×	2.4k 1.4×	777 0.5×	502 0.4×	247	6.8k
Amit Maity United States	45	2.7k 0.7×	3.4k 1.9×	1.9k 1.1×	572 0.4×	1.0k 0.7×	153	7.2k
Stefania Bellone United States	41	2.4k 0.6×	1.8k 1.0×	761 0.4×	609 0.4×	1.4k 1.0×	155	5.4k
Christian F. Singer Austria	45	3.0k 0.8×	2.0k 1.1×	2.1k 1.2×	817 0.5×	455 0.3×	267	6.4k
Isabelle Treilleux France	47	3.6k 1.0×	3.1k 1.8×	1.7k 1.0×	361 0.2×	2.3k 1.6×	219	7.9k
Phuoc T. Tran United States	47	2.3k 0.6×	2.5k 1.4×	1.2k 0.7×	1.0k 0.7×	785 0.5×	254	6.4k
Patrick G. Morris United States	33	2.8k 0.7×	1.6k 0.9×	1.2k 0.7×	538 0.3×	684 0.5×	136	5.2k

Countries citing papers authored by Suzy Scholl

Since Specialization

Citations

This map shows the geographic impact of Suzy Scholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzy Scholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzy Scholl more than expected).

Fields of papers citing papers by Suzy Scholl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzy Scholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzy Scholl. The network helps show where Suzy Scholl may publish in the future.

Co-authorship network of co-authors of Suzy Scholl

This figure shows the co-authorship network connecting the top 25 collaborators of Suzy Scholl. A scholar is included among the top collaborators of Suzy Scholl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzy Scholl. Suzy Scholl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Latouche, Aurélien, Felix Bruno Kleine Borgmann, Jean‐Jacques Gérardy, et al.. (2023). Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome. Human Pathology. 143. 62–70.

Scholl, Suzy, et al.. (2023). RAIDS atlas of significant genetic and protein biomarkers in cervical cancer. Journal of Gynecologic Oncology. 34(5). e74–e74. 1 indexed citations

Jeannot, Emmanuelle, Aurélien Latouche, Claire Bonneau, et al.. (2022). 2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse. International Journal of Gynecological Cancer. 32. A404–A404. 1 indexed citations

Bagnoli, Marina, Tingyan Shi, Charlie Gourley, et al.. (2019). Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions. Cells. 8(3). 200–200. 6 indexed citations

Massonnet, Gérald, David Gentien, Zofia Maciorowski, et al.. (2016). Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization. PLoS ONE. 11(7). e0157670–e0157670. 9 indexed citations

Samuels, Sanne, Balázs Bálint, Heiko von der Leyen, et al.. (2016). Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study. British Journal of Cancer. 115(12). 1575–1583. 6 indexed citations

Péguillet, Isabelle, Maud Milder, Delphine Louis, et al.. (2014). High Numbers of Differentiated Effector CD4 T Cells Are Found in Patients with Cancer and Correlate with Clinical Response after Neoadjuvant Therapy of Breast Cancer. Cancer Research. 74(8). 2204–2216. 29 indexed citations

Ngô, Charlotte, Corine Plancher, Anne de la Rochefordière, et al.. (2014). Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: A comparative study in 363 patients. European Journal of Surgical Oncology. 40(10). 1237–1244. 14 indexed citations

Garderet, Laurent, Hua Cao, Jean Salamero, et al.. (2001). In Vitro Production of Dendritic Cells from Human Blood Monocytes for Therapeutic Use. Journal of Hematotherapy & Stem Cell Research. 10(4). 553–567. 24 indexed citations

10.

Scholl, Suzy, Philippe Beuzeboc, & P Pouillart. (2001). Targeting HER2 in other tumor types. Annals of Oncology. 12. S81–S87. 120 indexed citations

11.

Cao, Hua, Véronique Vergé, Carole Baron, et al.. (2000). Cutting Edge Communication: In Vitro Generation of Dendritic Cells from Human Blood Monocytes in Experimental Conditions Compatible for In Vivo Cell Therapy. Journal of Hematotherapy & Stem Cell Research. 9(2). 183–194. 43 indexed citations

12.

Braud, A.C., Bernard Asselain, Suzy Scholl, et al.. (1999). Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?. European Journal of Cancer. 35(3). 392–397. 13 indexed citations

13.

García-Giralt, E, Philippe Beuzeboc, Véronique Dièras, et al.. (1996). Phase II Trial of Decapeptyl (D-TRP-6), a Potent Luteinizing Hormone-Releasing Hormone Analogue in Untreated Advanced Breast Cancer. American Journal of Clinical Oncology. 19(5). 455–458. 6 indexed citations

14.

Rochefordière, Anne de la, et al.. (1994). Simultaneous bilateral breast carcinomas: A retrospective review of 149 cases. International Journal of Radiation Oncology*Biology*Physics. 30(1). 35–41. 58 indexed citations

15.

Palangié, T, Véronique Mosseri, J. Mihura, et al.. (1994). Prognostic factors in inflammatory breast cancer and therapeutic implications. European Journal of Cancer. 30(7). 921–927. 70 indexed citations

16.

Scholl, Suzy, Alain Fourquet, Bernard Asselain, et al.. (1994). Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. European Journal of Cancer. 30(5). 645–652. 337 indexed citations

17.

Balmain, Allan, J. Carl Barrett, Harold L. Moses, et al.. (1993). Is colony‐stimulating factor‐1 a key mediator of breast cancer invasion and metastasis?. Molecular Carcinogenesis. 7(4). 207–211. 31 indexed citations

18.

Tang, Ruoping, Mario Ojeda‐Uribe, P Pouillart, et al.. (1992). M‐CSF (monocyte colony stimulating factor) and M‐CSF receptor expression by breast tumour cells: M‐CSF mediated recruitment of tumour infiltrating monocytes?. Journal of Cellular Biochemistry. 50(4). 350–356. 86 indexed citations

19.

Tang, Ruoping, Barry M. Kacinski, Pierre Validire, et al.. (1990). Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells?. Journal of Cellular Biochemistry. 44(3). 189–198. 57 indexed citations

20.

Belli, Laura, Suzy Scholl, Alain Livartowski, et al.. (1989). Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients. Cancer. 63(12). 2546–2550. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact